Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

USA - NYSE:NXRT - US65341D1028 - REIT

31.45 USD
+0.74 (+2.41%)
Last: 11/7/2025, 8:04:00 PM
31.45 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

3

NXRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. NXRT has a bad profitability rating. Also its financial health evaluation is rather negative. NXRT has a expensive valuation and it also scores bad on growth. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NXRT had negative earnings in the past year.
In the past year NXRT had a positive cash flow from operations.
Of the past 5 years NXRT 4 years were profitable.
NXRT had a positive operating cash flow in each of the past 5 years.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -2.68%, NXRT is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
With a Return On Equity value of -14.29%, NXRT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.22%, NXRT is doing worse than 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NXRT is in line with the industry average of 2.61%.
Industry RankSector Rank
ROA -2.68%
ROE -14.29%
ROIC 1.22%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of NXRT has declined.
Looking at the Operating Margin, with a value of 11.11%, NXRT is doing worse than 75.00% of the companies in the same industry.
In the last couple of years the Operating Margin of NXRT has grown nicely.
NXRT has a better Gross Margin (62.76%) than 80.00% of its industry peers.
NXRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.11%
PM (TTM) N/A
GM 62.76%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NXRT is destroying value.
Compared to 1 year ago, NXRT has less shares outstanding
NXRT has more shares outstanding than it did 5 years ago.
NXRT has a worse debt/assets ratio than last year.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

NXRT has an Altman-Z score of 0.45. This is a bad value and indicates that NXRT is not financially healthy and even has some risk of bankruptcy.
NXRT has a worse Altman-Z score (0.45) than 65.00% of its industry peers.
The Debt to FCF ratio of NXRT is 32.74, which is on the high side as it means it would take NXRT, 32.74 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NXRT (32.74) is comparable to the rest of the industry.
NXRT has a Debt/Equity ratio of 4.22. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.22, NXRT is doing worse than 85.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 32.74
Altman-Z 0.45
ROIC/WACC0.16
WACC7.67%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.03 indicates that NXRT should not have too much problems paying its short term obligations.
The Current ratio of NXRT (1.03) is better than 80.00% of its industry peers.
NXRT has a Quick Ratio of 1.03. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NXRT (1.03) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

NXRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.25%.
Measured over the past years, NXRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -65.41% on average per year.
NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -4.46%.
The Revenue has been growing slightly by 7.48% on average over the past years.
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%

3.2 Future

Based on estimates for the next years, NXRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -287.31% on average per year.
NXRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.48% yearly.
EPS Next Y-6407.02%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
EPS Next 5YN/A
Revenue Next Year-2.51%
Revenue Next 2Y0.18%
Revenue Next 3Y1.61%
Revenue Next 5Y2.48%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

NXRT's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, NXRT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.81
EV/EBITDA 17.91
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as NXRT's earnings are expected to decrease with -287.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.90%, NXRT is a good candidate for dividend investing.
NXRT's Dividend Yield is rather good when compared to the industry average which is at 7.38. NXRT pays more dividend than 85.00% of the companies in the same industry.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 6.9%

5.2 History

The dividend of NXRT is nicely growing with an annual growth rate of 10.88%!
NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
As NXRT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of NXRT are negative and hence is the payout ratio. NXRT will probably not be able to sustain this dividend level.
DP-104.31%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (11/7/2025, 8:04:00 PM)

After market: 31.45 0 (0%)

31.45

+0.74 (+2.41%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners75.78%
Inst Owner Change-0.29%
Ins Owners13.32%
Ins Owner Change1.53%
Market Cap797.57M
Revenue(TTM)252.99M
Net Income(TTM)-49.71M
Analysts72.86
Price Target36.04 (14.59%)
Short Float %2.42%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield 6.9%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-104.31%
Div Incr Years9
Div Non Decr Years9
Ex-Date12-15 2025-12-15 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.59%
Min EPS beat(2)8.72%
Max EPS beat(2)18.46%
EPS beat(4)2
Avg EPS beat(4)-44.01%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)5
Avg EPS beat(8)52.88%
EPS beat(12)6
Avg EPS beat(12)9.02%
EPS beat(16)9
Avg EPS beat(16)54.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.64%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.22%
Revenue beat(12)3
Avg Revenue beat(12)1.86%
Revenue beat(16)6
Avg Revenue beat(16)1.46%
PT rev (1m)-0.47%
PT rev (3m)-6.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.48%
EPS NY rev (1m)0.54%
EPS NY rev (3m)-1.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.14
P/FCF 17.81
P/OCF 9.68
P/B 2.29
P/tB 2.29
EV/EBITDA 17.91
EPS(TTM)-1.89
EYN/A
EPS(NY)-1.25
Fwd EYN/A
FCF(TTM)1.77
FCFY5.62%
OCF(TTM)3.25
OCFY10.34%
SpS10.03
BVpS13.72
TBVpS13.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -14.29%
ROCE 1.55%
ROIC 1.22%
ROICexc 1.23%
ROICexgc 1.25%
OM 11.11%
PM (TTM) N/A
GM 62.76%
FCFM 17.62%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexgc growth 3Y22.72%
ROICexgc growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 32.74
Debt/EBITDA 11.67
Cap/Depr 38.64%
Cap/Sales 14.8%
Interest Coverage 0.3
Cash Conversion 65.61%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 0.45
F-Score4
WACC7.67%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
EPS Next Y-6407.02%
EPS Next 2Y-703.28%
EPS Next 3Y-287.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%
Revenue Next Year-2.51%
Revenue Next 2Y0.18%
Revenue Next 3Y1.61%
Revenue Next 5Y2.48%
EBIT growth 1Y-24.73%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18452.7%
EBIT Next 3Y497.35%
EBIT Next 5Y288.05%
FCF growth 1Y183.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.62%
OCF growth 3Y0.14%
OCF growth 5Y7.45%

NEXPOINT RESIDENTIAL / NXRT FAQ

Can you provide the ChartMill fundamental rating for NEXPOINT RESIDENTIAL?

ChartMill assigns a fundamental rating of 3 / 10 to NXRT.


What is the valuation status of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


How financially healthy is NEXPOINT RESIDENTIAL?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 3 / 10.